Eric C. Sayre

Eric C. Sayre

Auto-generated profile, based on publicly available information

Eric C. Sayre

British Columbia Centre on Substance Use, Vancouver, Canada

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2018 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
LFLynne M Feehan
Lynne M Feehan
JGJasmina Geldman
Jasmina Geldman
ESEric C Sayre
Eric C Sayre
CPChance Park
Chance Park
AEAllison M Ezzat
Allison M Ezzat
LLLinda C Li
Linda C Li
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Wearable Fitbit activity trackers are increasingly being used as outcome measurement tools in research and to inform healthcare decisions. However, the accuracy of these devices has not been systematically evaluated. Objective: To quantify Fitbit device measurement accuracy in controlled and free-living settings. Methods: Electronic searches using PubMed, Embase, CINAHL and SportsDiscus databases with a supplementary Google Scholar search. Original research published in English comparing Fitbit device measurements to a gold- or research-standard criterion in adults living with any health, disease or functional status. Risk of bias was assessed using a modified validation subscale in the COnsensus-based Standards for the selection of health status Measurement INstruments (COSMIN). We identified and synthesized percent measurement error estimates for Fitbit measures of steps, energy expenditure (EE), sleep, distance and time in activity. Results: 67 studies met the inclusion criteria, with 57 incorporated in the quantitative syntheses. Respectively, 40, 21, 8, 6 and 2 studies included measures of steps, EE, time in activity, sleep and distance. Fitbit devices demonstrated acceptable accuracy in controlled settings (Mean % error: +/-3%) for measures of steps taken at normal, jogging and very slow walking speeds when worn on the torso, wrist and ankle respectively, and acceptable accuracy for measures of EE at rest and during very slow walking and for distance measures at normal walking speeds when worn on the wrist. Notable inaccuracies in controlled settings were underestimations of steps during household or sporting activities (Mean: -35.4%; SD: 20.5%) or when using a walking aid (Mean: -20.9%; SD: 22.4%), and underestimations of EE during inclined ambulation (Mean: -18.7%; SD: 22.2%) and overestimations of EE for walking on flat surfaces (Mean: 16.7%; SD: 31.4%). In free-living settings, Fitbit demonstrated acceptable relative accuracy (Mean % error: +/-10%) compared to a research-standard criterion for measures of daily steps when worn on the torso, as well as measures of time in bed and total EE over 15 days. Notable relative inaccuracies in free-living settings were mean error overestimations varying from 30% to 600% for time spent in light through vigorous activity and underestimation of daily steps in mobility-limited older adults (Mean: -24.3%; SD: 9.0%). Conclusions: Other than measures of steps during typical walking activities and EE at rest and across a number of days, the Fitbit activity trackers reviewed showed limited measurement accuracy in both controlled and free-living settings. Given the current limitations of Fitbit’s measurement accuracy, discretion should be exercised when using these devices as an outcome measurement tool in research or to inform healthcare decisions. Clinical Trial: N/A

18 November 2010 in BMC Public Health
Verified
Journal Article
Open access
PDF file
JKJacek Kopec
Jacek Kopec
PFPhilippe Finès
Philippe Finès
DMDoug G Manuel
Doug G Manuel
DBDavid L Buckeridge
David L Buckeridge
WFWilliam M Flanagan
William M Flanagan
MWMichael C Wolfson
Michael C Wolfson
Computer simulation models are used increasingly to support public health research and policy, but questions about their quality persist. The purpose of this article is to review the principles and methods for validation of population-based disease simulation models.

26 June 2017 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
LLLinda C Li
Linda C Li
ESEric C Sayre
Eric C Sayre
HXHui Xie
Hui Xie
CCCam Clayton
Cam Clayton
LFLynne M Feehan
Lynne M Feehan
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

30 April 2018 in Journal of Medical Internet Research
Verified
Journal Article
Open access
LLLinda C Li
Linda C Li
ESEric C Sayre
Eric C Sayre
HXHui Xie
Hui Xie
RFRyan S Falck
Ryan S Falck
JBJohn R Best
John R Best
LFLynne M Feehan
Lynne M Feehan
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

15 December 2006
Verified
Journal Article
Closed access
JKJacek Kopec
Jacek Kopec
MRM Mushfiqur Rahman
M Mushfiqur Rahman
JBJean-Marie Berthelot
Jean-Marie Berthelot
CPChristel Le Petit
Christel Le Petit
JAJaafar Aghajanian
Jaafar Aghajanian
EBElizabeth M Badley
Elizabeth M Badley

27 March 2013 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
MHMichael A Hunt
Michael A Hunt
CPCourtney L Pollock
Courtney L Pollock
VKVirginia Byers Kraus
Virginia Byers Kraus
TSTore Saxne
Tore Saxne
SPSue Peters
Sue Peters
JCJolanda Cibere
Jolanda Cibere
Little is known about the relationships of circulating levels of biomarkers of cartilage degradation with biomechanical outcomes relevant to knee osteoarthritis (OA) or biomarker changes following non-pharmacological interventions. The objectives of this exploratory, pilot study were to: 1) examine relationships between biomarkers of articular cartilage degradation and synthesis with measures of knee joint load during walking, and 2) examine changes in these biomarkers following 10 weeks of strengthening exercises. Seventeen (8 male, 9 female; 66.1 +/- 11.3 years of age) individuals with radiographically-confirmed medial tibiofemoral OA participated. All participants underwent a baseline testing session where serum and urine samples were collected, followed by a three-dimensional motion analysis. Motion analysis was used to calculate the external knee adduction moment (KAM) peak value and impulse. Following baseline testing, participants were randomized to either 10 weeks of: 1) physiotherapist-supervised lower limb muscle strengthening exercises, or 2) no exercises (control). Identical follow-up testing was conducted 11 weeks after baseline. Biomarkers included: urinary C-telopeptide of type II collagen (uCTX-II) and type II collagen cleavage neoepitope (uC2C), serum cartilage oligomeric matrix protein (sCOMP), serum hyaluronic acid (sHA) and serum C-propeptide of type II procollagen (sCPII). Linear regression analysis was used to examine relationships between measures of the KAM and biomarker concentrations as baseline, as well as between-group differences following the intervention. KAM impulse predicted significant variation in uCTX-II levels at baseline (p = 0.04), though not when controlling for disease severity and walking speed (p = 0.33). KAM impulse explained significant variation in the ratio uCTX-II;sCPII even when controlling for additional variables (p = 0.04). Following the intervention, changes in sCOMP were significantly greater in the exercise group compared to controls (p = 0.04). On average those in the control group experienced a slight increase in sCOMP and uCTX-II, while those in the exercise group experienced a reduction. No other significant findings were observed. This research provides initial evidence of a potential relationship between uCTX-II and knee joint load measures in patients with medial tibiofemoral knee OA. However, this relationship became non-significant after controlling for disease severity and walking speed, suggesting further research is necessary. It also appears that sCOMP is amenable to change following a strengthening intervention, suggesting a potential beneficial role of exercise on cartilage structure. Clinicaltrials.gov NCT01241812